Biognosys, Alamar Biosciences ink partnership agreement to advance biopharma
05 Apr 2024 //
PHARMABIZ
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
23 Jan 2024 //
BUSINESSWIRE
Biognosys Appoints Beat Lüthi, Ph.D., as independent Board Director
19 May 2022 //
BUSINESSWIRE
Biognosys and NeoGenomics Expand Global Strategic Partnership Initiatives
11 Apr 2022 //
BUSINESSWIRE
NeoGenomics Expands Its Global Strategic Partnership with Biognosys
11 Apr 2022 //
ACCESSWIRE
Biognosys Shows Data on TrueDiscovery, TrueTarget Proteomics Platforms at AACR
31 Mar 2022 //
BUSINESSWIRE
Biognosys Partners with Kymera Tx in Precision Proteomics Biomarkers
15 Mar 2022 //
BUSINESSWIRE
Biognosys Launches Expanded Suite of Proteomics Platforms
03 Mar 2022 //
BUSINESSWIRE
Biognosys Announces GLP Certification of Its Proteomics Facility
13 Jan 2022 //
BUSINESSWIRE
Biognosys Launches Next-Generation Blood Biomarker Discovery Solution
09 Nov 2021 //
BUSINESSWIRE
Biognosys to Present Major Scientific & Technological Advances at ASMS 2021
21 Oct 2021 //
BUSINESSWIRE
Biognosys Supports Cancer Scout
12 Oct 2021 //
BUSINESSWIRE
Biognosys collaborates with Evotec to advance next-generation proteomics
14 Sep 2021 //
BUSINESSWIRE
Biognosys Announces Strategic Agreement with Siemens Healthineers
13 Apr 2021 //
BUSINESSWIRE